Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Rangering i aksjer #24698
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Aksjekurs
$0.95011029
Sist synkronisert: 2023-06-28
Markedsverdi
$57.72M
Endring (1 dag)
8.53%
Endring (1 år)
0.00%
Land
FR
Handel ERYTECH Pharma S.A. (ERYP)

Kategori

Aksjeprishistorikk for ERYTECH Pharma S.A. (ERYP)
Høyeste sluttskurs: $0.90 den 2023-06-01

Laveste sluttskurs: $14.08 den 2013-05-01
Aksjeprishistorikk for ERYTECH Pharma S.A. fra 2013 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.00 38.88%
US
$1.05K 58.34%
NL
$152.13 480.21%
US
$118.70 -18.24%
AU
$769.41 9.73%
CH